PVLA
insider transactionsPALVELLA THERAPEUTICS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 2 different insiders made open-market purchases in the last 90 days, totalling $1.0M.
Net shares · 90d
+27.8K
36.4K buy · 8.6K sell
Net value · 90d
$26.9K
$1.0M in · $1.0M out
Sentiment · 90d
Net buying
51% buying · 49% selling
Open-market trades · 90d
11
36.4K buy · 8.6K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Buy·P
Director
$14.4K
503 sh · $28.73
Own +1%
-
Buy·P
Director
$985.5K
35.4K sh · $27.80
Own +89%
-
Grant·A
Director
$0
3.0K sh
Own New
-
Grant·A
Director
$0
3.0K sh
Own New
-
Grant·A
Director
$0
3.0K sh
Own New
-
Grant·A
Director
$0
3.0K sh
Own New
-
Grant·A
Director
$0
3.0K sh
Own New
-
Grant·A
Director
$0
3.0K sh
Own New
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
2.1K sh
Own +25%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
2.2K sh
Own +25%
-
Sell·S
Chief Operating Officer · 10b5-1
$5.4K
48 sh · $111.90
Own -100%
-
Sell·S
Chief Operating Officer · 10b5-1
$99.2K
891 sh · $111.30
Own -95%
-
Sell·S
Chief Operating Officer · 10b5-1
$371.1K
3.4K sh · $110.35
Own -78%
-
Exercise·M
Chief Operating Officer · 10b5-1
$19.5K
2.1K sh · $9.08
Own +100%
-
Exercise·M
Chief Operating Officer · 10b5-1
$15.4K
2.2K sh · $7.14
Own New
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
2.1K sh
Own +20%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
2.2K sh
Own +20%
-
Sell·S
Chief Operating Officer · 10b5-1
$13.0K
100 sh · $130.33
Own -100%
-
Sell·S
Chief Operating Officer · 10b5-1
$82.5K
639 sh · $129.17
Own -86%
-
Sell·S
Chief Operating Officer · 10b5-1
$71.9K
561 sh · $128.23
Own -43%
-
Sell·S
Chief Operating Officer · 10b5-1
$190.7K
1.5K sh · $127.13
Own -54%
-
Sell·S
Chief Operating Officer · 10b5-1
$189.2K
1.5K sh · $125.96
Own -35%
-
Exercise·M
Chief Operating Officer · 10b5-1
$19.5K
2.1K sh · $9.08
Own +100%
-
Exercise·M
Chief Operating Officer · 10b5-1
$15.4K
2.2K sh · $7.14
Own New
-
Grant·A
Director
$0
6.0K sh
Own New
-
Buy·P
Director
$50.0K
445 sh · $112.30
Own +0%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Todd C Davis | Buy P | 503 | $14.4K |
| Jun 11, 2026 | Todd C Davis | Buy P | 35.4K | $985.5K |
| Jun 10, 2026 | Tadd S. Wessel | Grant A | 3.0K | $0 |
| Jun 10, 2026 | Christopher P Kiritsy | Grant A | 3.0K | $0 |
| Jun 10, 2026 | George M Jenkins | Grant A | 3.0K | $0 |
| Jun 10, 2026 | Elaine J Heron | Grant A | 3.0K | $0 |
| Jun 10, 2026 | John Doux | Grant A | 3.0K | $0 |
| Jun 10, 2026 | Todd C Davis | Grant A | 3.0K | $0 |
| May 20, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.1K | $0 |
| May 20, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.2K | $0 |
| May 20, 2026 | Kathleen Goin 10b5-1 | Sell S | 48 | $5.4K |
| May 20, 2026 | Kathleen Goin 10b5-1 | Sell S | 891 | $99.2K |
| May 20, 2026 | Kathleen Goin 10b5-1 | Sell S | 3.4K | $371.1K |
| May 20, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.1K | $19.5K |
| May 20, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.2K | $15.4K |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.1K | $0 |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.2K | $0 |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Sell S | 100 | $13.0K |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Sell S | 639 | $82.5K |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Sell S | 561 | $71.9K |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Sell S | 1.5K | $190.7K |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Sell S | 1.5K | $189.2K |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.1K | $19.5K |
| Apr 15, 2026 | Kathleen Goin 10b5-1 | Exercise M | 2.2K | $15.4K |
| Apr 13, 2026 | John Doux | Grant A | 6.0K | $0 |
| Mar 30, 2026 | George M Jenkins | Buy P | 445 | $50.0K |
About PVLA insider trading
This page tracks insider transactions for PALVELLA THERAPEUTICS, INC. (PVLA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.